APP and Alzheimer disease: Direct Aβ1–40 or Aβ1–42 peptide transgene expression eliminates the need for any APP proteolytic processing, an admittedly different process from that which occurs in AD, but has the advantage of allowing direct observations of peptide routing unconfounded by uncertainties in the various sites proposed for APP proteolysis.